Back to results
US 2009/0269934 A1Published application
Plasma treatment method for preventing defects in doped silicon oxide surfaces during exposure to atmosphere
AssigneeApplied Materials, Inc.
InventorsChien-Teh Kao, Haichun Yang, Xinliang Lu, Mei Chang
Life of this patent
Estimating the term…
Abstract
Formation of BPSG surface defects upon exposure to atmosphere is prevented by a plasma treatment method for converting boron and/or phosphorus materials separated from silicon near the surface of the doped glass layer to gas phase compounds. The treatment plasma is generated from a treatment process gas containing one of (a) a fluorine compound or (b) a hydrogen compound.
Claims20
A method of fabricating an integrated circuit on a semiconductor wafer, comprising:
- forming a thin film device structure on the wafer including semiconductor elements;
- covering said thin film device structure with a doped glass layer comprising silicon, oxygen and at least one of boron or phosphorus;
- forming openings through said doped glass layer to expose a surface of each of said semiconductor elements;
- performing an etch step by generating a plasma from a process gas comprising fluorine species and hydrogen species and exposing said wafer to by-products of said plasma;
- converting boron and/or phosphorus materials separated from silicon near the surface of said doped glass layer to gas phase compounds.
2 more elements
A method of fabricating an integrated circuit on a semiconductor wafer, comprising:
- forming a thin film device structure on the wafer including semiconductor elements;
- covering said thin film device structure with a doped glass layer comprising silicon, oxygen and at least one of boron or phosphorus;
- forming openings through said doped glass layer to expose a surface of each of said semiconductor elements;
- performing an etch step by generating a plasma from a process gas comprising fluorine species and hydrogen species and exposing said wafer to by-products of said plasma;
- generating a treatment plasma from a treatment process gas containing one of (a) a fluorine compound or (b) a hydrogen compound so as to produce plasma treatment by-products from said plasma;
- exposing said wafer to said plasma treatment by-products.
3 more elements
Dependencies are inferred from the claim text.